Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-14

Study Completion Date

2018-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population

NCT03581825

Visual Acuity

COMPLETED NA

Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population

NCT01763047

Presbyopia

COMPLETED NA

Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population

NCT03787472

Visual Acuity

COMPLETED NA

Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses

NCT02956460

Myopia

COMPLETED NA

Evaluation of an Investigational Multifocal Lens

NCT02223754

Presbyopia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Visual Acuity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test/Control

Hyperopic subjects who are habitual soft contact lens wearers between the ages of 40 and 70 years of age, will be randomized to sequence Test/Control. Alternative Spherical lenses will be used if optimization cannot be achieved with the Multifocal lenses.

Group Type EXPERIMENTAL

senofilcon A Multifocal

Intervention Type DEVICE

TEST Lens

senofilcon A Sphere

Intervention Type DEVICE

TEST Lens Sphere

etafilcon A Multifocal

Intervention Type DEVICE

CONTROL Lens

etafilcon A Sphere

Intervention Type DEVICE

CONTROL Lens Sphere

Control/Test

Hyperopic subjects who are habitual soft contact lens wearers between the ages of 40 and 70 years of age, will be randomized to sequence Control/Test. Alternative Spherical lenses will be used if optimization cannot be achieved with the Multifocal lenses.

Group Type EXPERIMENTAL

senofilcon A Multifocal

Intervention Type DEVICE

TEST Lens

senofilcon A Sphere

Intervention Type DEVICE

TEST Lens Sphere

etafilcon A Multifocal

Intervention Type DEVICE

CONTROL Lens

etafilcon A Sphere

Intervention Type DEVICE

CONTROL Lens Sphere

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

senofilcon A Multifocal

TEST Lens

Intervention Type DEVICE

senofilcon A Sphere

TEST Lens Sphere

Intervention Type DEVICE

etafilcon A Multifocal

CONTROL Lens

Intervention Type DEVICE

etafilcon A Sphere

CONTROL Lens Sphere

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

JJVC Investigational Multifocal Contact Lens ACUVUE OASYS 2-WEEK with HYDRACLEAR PLUS 1-Day Acuvue Moist Brand Multifocal Contact Lens 1-Day Acuvue Moist Brand Contact Lens

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Potential subjects must satisfy all the following criteria to be enrolled in the study:

1. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
2. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
3. The subject must be between 40 and 70 years of age (inclusive).
4. The subject's distance spherical equivalent refraction must be in the range of -1.25 D to -3.75 D in each eye.
5. The subject's refractive cylinder must be ≤0.75 D in each eye.
6. The subject's ADD power must be in the range of +0.75 D to +2.50 D.
7. The subject must have distance best corrected visual acuity of 20/20-3 or better in each eye.
8. Subjects must own a wearable pair of spectacles if required for their distance vision.
9. The subject must be an adapted soft contact lens wearer in both eyes (i.e. worn lenses a minimum of 2 days per week for at least 8 hours per wear day, for 1 month of more duration).
10. The subject must either already be wearing a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".

Exclusion Criteria

* Potential subjects who meet any of the following criteria will be excluded from participating in the study:

1. Currently pregnant or lactating.
2. Any active or ongoing ocular or systemic allergies that may interfere with contact lens wear.
3. Any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens-Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis).
4. Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities or bulbar injection, or any other corneal or ocular abnormalities which would contraindicate contact lens wear.
5. Entropion, ectropion, extrusions, chalazia, recurrent styes, dry eye, glaucoma, history of recurrent corneal erosions.
6. Any previous, or planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, cataract surgery, retinal surgery, etc.).
7. A history of amblyopia, strabismus or binocular vision abnormality.
8. Any current ocular infection or inflammation.
9. Any current ocular abnormality that may interfere with contact lens wear.
10. Use of any of the following oral medications within 1 week prior to enrollment: oral retinoid isotretinoin (e.g. Accutane), oral tetracyclines, topical scopolamine, oral antihistamines (e.g., Chlor-Trimeton, and Benadryl), systemic steroids.
11. Use of any ocular medication, with the exception of rewetting drops.
12. History of herpetic keratitis.
13. Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment.
14. Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
15. Any known hypersensitivity or allergic reaction to Optifree®Replenish® multipurpose care solution or Eye-Cept® rewetting drop solution.

Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes